Tower Research Capital LLC (TRC)

Position in ALLR — Allarity Therapeutics, Inc.

CIK 1533421 NEW YORK, NY

Position in ALLR

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$3,418

+$315 QoQ

Shares Held

2,650

-13.8% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#16

of 20 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,739,988 across 466 Biotechnology names. ALLR ranks #404 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	4,547	$4,218,570
2	BBIO	BridgeBio Pharma, Inc.	38,206	$2,845,582
3	ARWR	Arrowhead Pharmaceuticals, Inc.	34,537	$2,815,110
4	VRTX	Vertex Pharmaceuticals Inc / Ma	4,292	$2,131,964
5	MDGL	Madrigal Pharmaceuticals, Inc.	3,927	$2,108,602
6	AXSM	Axsome Therapeutics, Inc.	6,437	$1,575,584
7	INSM	INSMED Inc	10,927	$1,165,036
8	ROIV	Roivant Sciences Ltd.	32,746	$1,158,880

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,418	2,650	-13.8%	Shares	Defined	2026-08-11
2025-06-30	$3,103	3,073	-34.7%	Shares	Defined	2025-08-15
2025-03-31	$4,408	4,705	+10.3%	Shares	Defined	2025-05-15
2024-12-31	$4,991	4,266	+25.4%	Shares	Defined	2025-02-13
2024-09-30	$7,180	3,403	-72.0%	Shares	Defined	2024-11-14
2024-06-30	$2,590	12,164	+112.6%	Shares	Defined	2024-08-13
2024-03-31	$1,722	5,721	+3.3%	Shares	Defined	2024-05-15
2023-12-31	$3,050	5,537	-1.0%	Shares	Defined	2024-02-13
2023-09-30	$4,176	5,591	+291.3%	Shares	Defined	2023-11-14
2023-06-30	$9,431	1,429	+2.1%	Shares	Defined	2023-08-14
2023-03-31	$62	1,400	-27.7%	Shares	Other	2023-05-09
2022-12-31	$1	1,936	+21411.1%	Shares	Defined	2023-02-10
2021-12-31	—	9	—	Shares	Other	2022-02-14
No filing history on record for this holder in this stock.